Chardan Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO): "warrants a new look by investors"
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: OBIO) | Delayed: 6.03 +0.08 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.95 | 52 Week High | $ | |||
| Open | $5.89 | 52 Week Low | $ | |||
| Day High | $6.09 | P/E | N/A | |||
| Day Low | $5.79 | EPS | $ | |||
| Volume | 284,802 | |||||
